Literature DB >> 15209765

Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes.

C-H Tseng1.   

Abstract

AIMS: Hyperuricaemia may be a risk factor for atherosclerotic disease. Its association with peripheral arterial disease (PAD) has not been studied in Taiwanese patients with Type 2 diabetes.
METHODS: Uric acid (UA) levels and PAD were evaluated in 508 Taiwanese outpatients with Type 2 diabetes (210 men, 298 women; mean age +/- sd, 63.8 +/- 10.6 years). PAD was diagnosed when the ankle-brachial index was < 0.9. Patients with an ankle-brachial index of > or = 1.3 were excluded because of possible medial arterial calcification. Potential confounding variables with P < 0.10 were adjusted for in multivariate analyses.
RESULTS: In univariate analyses, UA levels were higher in patients with PAD than in those without PAD (345.0 +/- 95.2 vs. 309.3 +/- 89.2 micromol/l; P < 0.0005). Prevalences of PAD for quintiles of UA levels were 6.8, 8.9, 10.2, 13.1 and 16.5%, respectively (P-trend < 0.05). With UA level as a continuous variable, the multivariate-adjusted odds ratio (95% confidence interval) for PAD was 1.005 (1.001-1.008) (P < 0.01). The optimal cut-off point for UA as determined by the receiver operating characteristic curve was 264.7 micromol/l. The sensitivity and specificity at this cut-off point was 82.6 and 33.3%, respectively. The area under curve was 0.60 (95% confidence interval: 0.53-0.68). The multivariate-adjusted odds ratio for PAD for UA above this level was 2.736 (1.239-6.043) (P < 0.05). The results after excluding 56 cases using diuretics were similar.
CONCLUSIONS: Elevated uric acid level is a significant and independent risk factor for PAD in Taiwanese patients with Type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15209765     DOI: 10.1111/j.1464-5491.2004.01239.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  22 in total

Review 1.  Hyperuricemia and risk of stroke: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Rheum       Date:  2009-07-15

Review 2.  The role of triglyceride in cardiovascular disease in asian patients with type 2 diabetes--a systematic review.

Authors:  Ai-Hua Chen; Chin-Hsiao Tseng
Journal:  Rev Diabet Stud       Date:  2013-08-10

Review 3.  Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

4.  Uric acid crystal could inhibit Numb-induced URAT1 lysosome degradation in uric acid nephropathy.

Authors:  Xinlin Wu; Jianqing Zhang; Taoli Liu; Miansheng Yan; Heng Liu; Hongbo Xie; Shijun Zhang; Baoguo Sun; Bin Ke; Houming Zhou
Journal:  J Physiol Biochem       Date:  2015-03-17       Impact factor: 4.158

Review 5.  Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?

Authors:  Jesse Dawson; Matthew Walters
Journal:  Br J Clin Pharmacol       Date:  2006-12       Impact factor: 4.335

Review 6.  Comorbidities in patients with crystal diseases and hyperuricemia.

Authors:  Sebastian E Sattui; Jasvinder A Singh; Angelo L Gaffo
Journal:  Rheum Dis Clin North Am       Date:  2014-02-19       Impact factor: 2.670

7.  Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus.

Authors:  N Papanas; M Demetriou; N Katsiki; K Papatheodorou; D Papazoglou; T Gioka; S Kotsiou; E Maltezos; D P Mikhailidis
Journal:  Exp Diabetes Res       Date:  2011-09-15

8.  Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus.

Authors:  Hiroyuki Ito; Mariko Abe; Mizuo Mifune; Koshiro Oshikiri; Shinichi Antoku; Yuichiro Takeuchi; Michiko Togane
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

Review 9.  Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate.

Authors:  Melvin R Hayden; Suresh C Tyagi; Lisa Kolb; James R Sowers; Ramesh Khanna
Journal:  Cardiovasc Diabetol       Date:  2005-03-18       Impact factor: 9.951

10.  Association between Related Purine Metabolites and Diabetic Retinopathy in Type 2 Diabetic Patients.

Authors:  Jianfei Xia; Zonghua Wang; Feifei Zhang
Journal:  Int J Endocrinol       Date:  2014-02-13       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.